Girgis, Ragy R. http://orcid.org/0000-0001-5715-8982
Slifstein, Mark
Brucato, Gary
Kegeles, Lawrence S.
Colibazzi, Tiziano
Lieberman, Jeffrey A.
Abi-Dargham, Anissa http://orcid.org/0000-0002-5039-5069
Funding for this research was provided by:
Doris Duke Charitable Foundation
Brain and Behavior Research Foundation
Brain and Behavior Research Foundation
Article History
Received: 22 June 2020
Revised: 14 October 2020
Accepted: 22 October 2020
First Online: 5 November 2020
Compliance with ethical standards
:
: RRG has recently received research support from Otsuka, Allergan, BioAdvantex and Genentech and has received advances/royalties from books published by Wipf and Stock and Routledge/Taylor and Francis. MS has consulted for Curasen Therapeutics. GB discloses that he receives royalties and/or advances from Routledge/Taylor and Francis and Prometheus Books. LSK has received research support from Amgen. JAL has received support administered through his institution in the form of funding or medication supplies for investigator-initiated research from Lilly, Denovo, Biomarin, Novartis, Taisho, Teva, Alkermes, and Boehringer Ingelheim, and is a member of the advisory board of Intracellular Therapies and Pierre Fabre. He neither accepts nor receives any personal financial remuneration for consulting, advisory board or research activities. He holds a patent from Repligen and receives royalty payments from <i>SHRINKS: The Untold Story of Psychiatry</i>. AAD reports serving on an advisory board for Sunovion, receiving an honorarium from Otsuka, receiving stock options from Terran Biosciences and System1 Biosciences, and receiving research support from Neurocrine and LB Pharmaceuticals in the previous year. No other authors report relevant conflicts of interest.